Statistics from Altmetric.com
Funding Part of the research reported in this article was funded by grants EC 07/ 90077 and FIS PI080126 from the Instituto de Salud Carlos III. CIBERHED is funded by the Instituto de Salud Carlos III.
Competing interests AC is a consultant for Otsuka Pharmaceuticals and has been a consultant for Orphan Therapeutics and GlaxoSmithKline. PG has been a consultant for Otsuka Pharmaceuticals and Orphan Therapeutics.
Provenance and peer review Commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.